Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement: Feasibility
1 other identifier
interventional
69
0 countries
N/A
Brief Summary
Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. The goal of this feasibility study is to determine if using technological advancements to remotely, accurately, and securely monitor alcohol use with a newly developed breathalyzer is an effective treatment that is acceptable to participants. If validated, this treatment approach has the potential to facilitate the dissemination of an effective, evidence-based treatment for alcohol dependence to a broader population whose treatment needs are not currently being adequately met.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Nov 2014
Typical duration for phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 5, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2017
CompletedFirst Submitted
Initial submission to the registry
April 7, 2018
CompletedFirst Posted
Study publicly available on registry
April 24, 2018
CompletedApril 24, 2018
April 1, 2018
2.1 years
April 7, 2018
April 23, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Percent days abstinent from alcohol during intervention
Three breathalyzer assessments will be collected per day during the treatment period. This outcome measure will consist of the percent days when all three breathalyzers were on time and negative for alcohol.
Percent days abstinent is the aggregate measure throughout the 21-day intervention period
Treatment acceptability
Participant ratings of treatment acceptability will be collected during assessment sessions
Baseline, one day after treatment end, and at a one-month follow-up
Study Arms (2)
Contingent
ACTIVE COMPARATORThe Contingent group will receive nearly immediate monetary payments over the internet each day they remotely provide negative breathalyzer samples, but will not receive the payments if they provide positive samples or fail to provide samples in a timely manner.
Noncontingent
SHAM COMPARATORThe Noncontingent group will receive payments each day they successfully provide samples independent of the alcohol content of those samples.
Interventions
Monetary incentives are delivered to participants contingent upon on-time breathalyzer submissions and verified abstinence from alcohol.
Monetary incentives are delivered to participants contingent upon on-time breathalyzer submissions only with no contingency on alcohol use.
Eligibility Criteria
You may qualify if:
- At least 18 years old
- Provide written informed consent
- Meet Diagnostic and Statistical Manual criteria for alcohol use disorder
- Express a desire to cut down or quit drinking
You may not qualify if:
- Pregnant or lactating
- Meet Diagnostic and Statistical Manual criteria for other substance use disorder (except caffeine or nicotine)
- Score 23 or greater on the Alcohol Withdrawal Symptom Checklist
- Have immediate plans to move out of the area
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
April 7, 2018
First Posted
April 24, 2018
Study Start
November 15, 2014
Primary Completion
January 5, 2017
Study Completion
January 5, 2017
Last Updated
April 24, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
Final research data for this project will be made as available as possible, while safeguarding the privacy of participants and protecting all confidential and proprietary data. Data will be available for use after the main findings from the final dataset have been accepted for publication. The data and associated documentation will only be made available to users under a Data Use Agreement that provides for 1) a commitment to using the data only for research purposes and not to identify any individual participant and 2) a commitment to destroying or returning the data after analyses are completed. To ensure compliance with HIPAA regulations, only a Limited Data Set will be available for use. The method of data release will be determined on a case-by-case basis depending upon the amount and type of data required.